Therapeutic Targeting of the Bcl-6: p53 Axis with Histone Deacetylase Inhibitors in Diffuse Large B-Cell Lymphoma

被引：0
|
作者：
Amengual, Jennifer E. [1 ]
Kalac, Matko [1 ]
Scotto, Luigi [1 ]
Sleckman, Patrick A. [2 ]
Marchi, Enrica [1 ]
Deng, Changchun [1 ]
Bongero, Danielle C. [1 ]
Jain, Salvia [1 ]
Buitrago, Jairo Baquero [1 ]
O'Connor, Owen A. [1 ]
机构：
[1] NYU Langone Med Ctr, NYU Canc Inst, New York, NY USA
[2] Lake Erie Coll Osteopath Med, Erie, PA USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1593 / 1594
页数：2
相关论文
共 50 条
  • [31] Prognostic significance of BCL-6 expression in diffuse large B-cell lymphomas (DLBCL)
    Karikehalli, S
    Nazeer, T
    MODERN PATHOLOGY, 2002, 15 (01) : 246A - 246A
  • [32] Increased histone deacetylase 6 expression serves as a favorable prognostic factor for diffuse large B-cell lymphoma
    Lin, Xiao-Ji
    Cai, Li-Meng
    Qian, Zi-Jun
    Wang, Chen-Yi
    Sun, Ni
    Sun, Xiao-Hai
    Huang, He
    Guo, Wen-Jian
    Lin, Hai-Yan
    Yao, Rong-Xin
    ONCOTARGETS AND THERAPY, 2017, 10 : 5129 - 5136
  • [33] Expression. of p53, c-myc, or bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals
    Chang, CC
    Kampalath, B
    Schultz, C
    Bunyi-Teopengco, E
    Logan, B
    Eshoa, C
    Dincer, AP
    Perkins, SL
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2003, 127 (02) : 208 - 212
  • [34] Targeted Polymersome Delivery of a Stapled Peptide for Drugging the Tumor Protein p53:BCL-2-Family Axis in Diffuse Large B-Cell Lymphoma
    Schnorenberg, Mathew R.
    Hawley, Katrina M.
    Thomas-Toth, Anika T.
    Watkins, Elyse A.
    Tian, Yu
    Ting, Jeffrey M.
    Leak, Logan B.
    Kucera, Isadora M.
    Raczy, Michal M.
    Kung, Andrew L.
    Hubbell, Jeffrey A.
    Tirrell, Matthew V.
    LaBelle, James L.
    ACS NANO, 2023, 17 (23) : 23374 - 23390
  • [35] Histone deacetylase inhibitors activate CIITA and MHC class II antigen expression in diffuse large B-cell lymphoma
    Cycon, Kelly A.
    Mulvaney, Kathleen
    Rimsza, Lisa M.
    Persky, Daniel
    Murphy, Shawn P.
    IMMUNOLOGY, 2013, 140 (02) : 259 - 272
  • [36] Histone Deacetylase Inhibitors Synergistically Enhance the Cytotoxic Effect of Hypomethylating Agents in Models of Diffuse Large B-Cell Lymphoma
    Kalac, Matko
    Kitagawa, Yukiko
    Venkatraman, Seshan Ennapadam
    Tycko, Benjamin
    O'Connor, Owen A.
    BLOOD, 2009, 114 (22) : 1433 - 1433
  • [37] Bcl-6 expression and lactate dehydrogenase level predict prognosis of primary gastric diffuse large B-cell lymphoma
    Chung, Kun-Ming
    Chang, Sheng-Tsung
    Huang, Wen-Tsung
    Lu, Chin-Li
    Wu, Hung-Chang
    Hwang, Wei-Shou
    Chang, Kwang-Yu
    Chuang, Shih-Sung
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2013, 112 (07) : 382 - 389
  • [38] Bcl-6 and CD10 expression may help predict outcome in diffuse large B-cell lymphoma
    不详
    CLINICAL LYMPHOMA, 2002, 3 (03): : 139 - 140
  • [39] Bcl-6 and c-Myc are rarely co-expressed in adult diffuse large B-cell lymphoma
    Wagner, Simon D.
    Amen, Furrat
    Trivedi, Pritesh S.
    Horncastle, Donna
    Elderfield, Kay
    Naresh, Kikkeri N.
    LEUKEMIA & LYMPHOMA, 2007, 48 (08) : 1510 - 1513
  • [40] Prognostic Significance of P53, Bcl-2, and Fas Expression in Patients with Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
    Cakmak, Erol
    Sari, Ismail
    Canoz, Ozlem
    Eser, Bulent
    Altuntas, Fevzi
    Cetin, Mustafa
    Unal, Ali
    ERCIYES MEDICAL JOURNAL, 2015, 37 (03) : 102 - 105
12345